A Study to Evaluate Safety and Immunogenicity of DelNS1-nCoV-RBD LAIV for COVID-19
Clinical trial NCT04809389 · UNKNOWN
Trial details
- NCT number
- NCT04809389
- Sponsor
- The University of Hong Kong
- Status
- UNKNOWN
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2021-03-29
- Primary completion
- 2022-09-01
- Enrollment
- 115
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.